education and awareness related to COVID-19 therapeutics
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | INVIVYD, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$20,000 | |
| 2025 | INVIVYD, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$20,000 | |
| 2025 | INVIVYD, INC. |
4th Quarter (Oct 1 - Dec 31) AMENDED |
— | |
| 2024 | INVIVYD, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Termination (No Activity) |
$20,000 | |
| 2023 | INVIVYD, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2023 | INVIVYD, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2023 | INVIVYD, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2023 | INVIVYD, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2023 | INVIVYD, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2022 | INVIVYD, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$70,000 |
| Firm | Filings | Expenses |
|---|---|---|
| INVIVYD, INC. | 14 | $200,000 |
| Issue | Activities |
|---|---|
| Health Issues | 11 |
| Medical/Disease Research/Clinical Labs | 9 |